Clinical Trials Logo

Healthy Volunteers clinical trials

View clinical trials related to Healthy Volunteers.

Filter by:

NCT ID: NCT05100901 Terminated - Healthy Volunteers Clinical Trials

Tolerance and Safety of an Oral Nutritional Supplement

Start date: September 24, 2021
Phase: N/A
Study type: Interventional

This is an open label, non-randomized, interventional, single arm study.

NCT ID: NCT05099822 Terminated - Healthy Volunteers Clinical Trials

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-97489 in Healthy Adult Participants

Start date: March 13, 2020
Phase: Phase 1
Study type: Interventional

This study aims to evaluate the safety, tolerability, of CC-97489

NCT ID: NCT04909723 Terminated - Healthy Volunteers Clinical Trials

Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects

Start date: June 2, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

The first stage of this study is a prospective, adaptive, Phase 1, first-in-human, randomized, controlled study evaluating safety, tolerability, and pharmacodynamics of NOV-001 in adult healthy volunteers. The second stage of this study is a prospective, randomized, single-blinded, placebo-controlled study of safety, tolerability, and early efficacy in patients with enteric hyperoxaluria.

NCT ID: NCT04896632 Terminated - Healthy Volunteers Clinical Trials

Study of Safety, Tolerability, and Pharmacokinetics of INE963 in Healthy Participants

Start date: May 13, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of single ascending doses and multiple doses of INE963 given orally in healthy participants.

NCT ID: NCT04845321 Terminated - Healthy Volunteers Clinical Trials

VNRX-9945 Safety and Pharmacokinetics in Healthy Adult Volunteers

Start date: June 23, 2021
Phase: Phase 1
Study type: Interventional

This is a 2-part first-in-human dose-ranging study to evaluate the safety and pharmacokinetics of escalating doses of VNRX-9945.

NCT ID: NCT04836494 Terminated - Healthy Volunteers Clinical Trials

A First in Human, Dose Escalation Study to Evaluate the Safety and Tolerability of BBP-671 in Healthy Volunteers and Patients With Propionic Acidemia or Methylmalonic Acidemia

Start date: March 25, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety, tolerability, PK and PD of BBP-671 in healthy volunteers and patients with Propionic Acidemia or Methylmalonic Acidemia.

NCT ID: NCT04832516 Terminated - Healthy Volunteers Clinical Trials

Effect of Individualized Training Versus Non-individualized Training to Improve Quality of Life of Sedentary Employees

SELFIT
Start date: April 7, 2021
Phase: N/A
Study type: Interventional

The practice of a physical activity, even moderate, plays an important role in the prevention and the management of the main chronic non-communicable diseases (cardiovascular diseases, certain cancers, diabetes, obesity, osteoporosis ...) as well as by improving psychological health. Several studies have shown that physical activity has a positive impact on the economy of companies via the reduction of absenteeism and the improvement of productivity. However, it seems important to individualize these recommendations in order to prescribe the best possible dose of physical activity for each individual. In this project, the investigators want to test the physical qualities of employees in order to prescribe the best possible dose of physical activity with the ultimate goal of improving quality of life.

NCT ID: NCT04832139 Terminated - Healthy Volunteers Clinical Trials

A Study of Marstacimab to Compare Prefilled Pen (PFP) Device to Prefilled Syringe (PFS) Device

Start date: March 30, 2021
Phase: Phase 1
Study type: Interventional

The goal in this study is to show that there are not significant differences in biologic activity of the study drug when administered using either the prefilled pen and prefilled syringe.

NCT ID: NCT04616105 Terminated - Healthy Volunteer Clinical Trials

Study of the Safety, Tolerability, and Pharmacokinetics of REGN6490 in Healthy Japanese Adult Volunteers

Start date: November 18, 2020
Phase: Phase 1
Study type: Interventional

The primary objective of the study is to evaluate the safety and tolerability of 3 single ascending subcutaneous (SC) doses and 1 single intravenous (IV) dose of REGN6490 in healthy first-generation Japanese adult participants The secondary objectives of the study are: - To characterize the pharmacokinetic (PK) profile of single SC and IV doses of REGN6490 in healthy first-generation Japanese adult participants - Assess immunogenicity of REGN6490 in healthy first-generation Japanese adult participants dosed with a single IV or SC dose of REGN6490

NCT ID: NCT04616079 Terminated - Healthy Volunteer Clinical Trials

Ascending Dose Study of the Safety and Tolerability of REGN6490 in Healthy Volunteers

Start date: November 19, 2020
Phase: Phase 1
Study type: Interventional

The primary objective of the study is to evaluate the safety and tolerability of single ascending intravenous (IV) and subcutaneous (SC) doses of REGN6490 in healthy adult participants The secondary objectives of the study are to: - Characterize the pharmacokinetic (PK) profile of single IV and SC doses of REGN6490 in healthy adult participants - Assess immunogenicity of REGN6490 in healthy adult participants dosed with a single IV or SC dose of REGN6490